Ownership history in Qube Research & Technologies Ltd · 14 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in PACIRA BIOSCIENCES (PCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 16,307 | -67,732 | -80.6% | 0.00% | $420K | $25.77 |
| 2024 Q4 | REDUCED | 84,039 | -276,166 | -76.7% | 0.00% | $1.6M | $18.84 |
| 2024 Q3 | ADDED | 360,205 | +231,014 | +178.8% | 0.01% | $5.4M | $15.05 |
| 2024 Q2 | ADDED | 129,191 | +111,384 | +625.5% | 0.01% | $3.7M | $28.61 |
| 2023 Q3 | REDUCED | 17,807 | -19,203 | -51.9% | 0.00% | $546K | $30.68 |
| 2023 Q1 | REDUCED | 37,010 | -15,694 | -29.8% | 0.01% | $1.5M | $40.81 |
| 2022 Q4 | ADDED | 52,704 | +28,950 | +121.9% | 0.01% | $2.0M | $38.61 |
| 2022 Q2 | ADDED | 23,754 | +15,956 | +204.6% | 0.01% | $1.4M | $58.30 |
| 2021 Q4 | REDUCED | 7,798 | -768 | -9.0% | 0.00% | $469K | $60.17 |
| 2021 Q3 | REDUCED | 8,566 | -32 | -0.4% | 0.01% | $480K | $56.00 |
As of 2025 Q4 — sorted by position size